Revelation Biosciences Inc (REVB) - Gross Profitability

Official company branding of Revelation Biosciences Corp (REVB)

Revelation Biosciences relies on a virtual model, outsourcing clinical trials and manufacturing to external partners. Gross sales margins demonstrate a recovery in profitability, where the 0.00 indicator expresses the state of the metric. The company is implementing energy-saving measures in its research centers, although its current environmental footprint remains minimal due to the absence of proprietary plants and the transition to digital documentation.

Gross Profitability: revbiosciences.com (REVB) for 07/04/2022 - 11/20/2026

Comprehensive metric breakdowns and analytics for Revelation Bio (REVB)

- stock value and consensus price forecast:
Fundamental valuation:REVB - Revelation Biosciences Inc
Manufactured product of Revelation Biosciences Inc

Gross margin measures production efficiency by determining the portion of revenue remaining after direct product creation costs. For Revelation Biosciences (REVB), the median gross margin will serve as a key indicator of pricing power as immunomodulating therapies move beyond the clinical trial stage. Steady growth in this metric would confirm the scalability of the business model and the company's ability to convert regulatory approval into high operating profit.

Main competitors

argenx - Gross Profit Rate|Gross Profitability biontech.de|ABIVAX (ABVX) - Return on Sales by Gross Profit|Gross Margin ADMA|Gross Profit Ratio PTGX|Gross Profitability Immunovant Corp IMVT|Gross Margin Kiniksa Pharmaceuticals, Ltd. KNSA|GRFS - Gross Profitability|Return on Sales by Gross Profit Adaptive Biotechnologies ADPT|CLDX (Celldex Therapeutics, Inc.) - Return on Gross Profit|Aurinia Pharmaceuticals Inc. (AUPH) - Gross Margin|Return on Gross Profit BCRX|Gross Profit Margin Vera Therapeutics Inc VERA|Return on Gross Profit DNTH (Dianthus Pharma)|Return on Sales by Gross Profit Pharvaris N.V.|AbCellera Biologics Inc - Return on Gross Profit|Tourmaline Bio (TRML) - Gross Profit Margin|PGEN - Gross Profitability|Gross Profit Rate PHAR (Pharming Group NV)|NKTR: Gross Margin|Upstream Bio Corp - Gross Profit Rate|Gross Profitability Zenas Biopharma Inc|Immunome, Inc. (IMNM) - Return on Sales by Gross Profit|Gross Margin GOSS|Return on Gross Profit KalVista Pharmaceuticals, Inc. KALV|Gross Profitability Septerna SEPN|Pieris Pharmaceuticals (PVLA) - Gross Profit Margin|SVRA - Gross Profitability|Rigel Pharmaceuticals - Gross Profit Ratio|AnaptysBio Corp (ANAB) - Gross Profitability|ATXS - Return on Sales by Gross Profit|Gross Profitability enGene Holdings Inc.|RAPT: Gross Profit Rate|Gross Margin JBIO|Return on Gross Profit aclaristx.com ACRS|Gross Profitability Kyverna Therapeutics Inc. KYTX|Tiziana Life Sciences Ltd. (TLSA) - Gross Profit Margin|Cabaletta Bio, Inc - Gross Margin|Gross Profit Margin Ventyx Biosciences|THTX (theratech.com) - Return on Gross Profit|Return on Gross Profit Avalo Therapeutics, Inc|ELDN (Eledon Pharmaceuticals, Inc) - Gross Margin|Gross Profit Margin Agenus Inc. AGEN|Return on Gross Profit CLYM (Climb Bio, Inc.)|ZURA (Zura Bio Ltd) - Gross Profit Rate|Gross Profitability atyrpharma.com ATYR|Gross Margin Adagene Corp ADAG|IMA - Gross Profitability|Gross Profit Rate STTK (Shattuck Labs)|EQ: Gross Margin|Connect Biopharma (CNTB) - Gross Margin|Gross Profitability Immunic|Gross Margin atarabio.com|Gross Margin IFRX|Gross Margin X4 Pharma (XFOR)|Gross Margin ACET (adicetbio.com)|Gross Margin Celularity Inc. CELU|INMB - Gross Profitability|Gross Profit Rate BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Return on Gross Profit|Return on Gross Profit SAB Biotherapeutics Inc.|Return on Gross Profit AKTX|Return on Gross Profit enlivex.com (ENLV)|Gross Profitability Q32 Bio Inc. (QTTB)|GeoVax Labs, Inc. (GOVX) - Gross Sales Margin|Gross Margin EDSA (Edesa Biotech Corp)|Return on Sales by Gross Profit iBio (IBIO)|CARM - Gross Profitability|XTL Biopharmaceuticals (XTLB) - Return on Gross Profit|BOLT: Gross Margin|Return on Gross Profit HCW Biologics Inc.|Gross Profitability Aptevo|Gross Return on Sales AIM (AIM ImmunoTech, Inc.)|Gross Margin ADTX|Return on Sales by Gross Profit GRI Bio Corp|Gross Margin XRTX (XORTX Therapeutics Inc)|Vyome Holdings (HIND) - Gross Profit Margin|Indaptus - Gross Margin|SCNI (Scinai Immunotherapeutics Ltd.) - Gross Return on Sales|CALI: Gross Margin|Affimed NV - Gross Profit Rate|Gross Profitability Allakos Inc.|Gross Margin HOOKIPA Pharma|Gross Profitability IGM Biosciences, Inc. (IGMS)|ITOS - Gross Profit Margin|Gross Margin OCEA (Ocean Bio)|Gross Profit Rate TCBP|THRD - Gross Profitability